跳至主要内容
临床试验/NCT01379560
NCT01379560已完成2 期

A Study to Evaluate the Ocular Blood Flow Effects of Unoprostone Isopropyl in Adults With Dry Age-related Macular Degeneration

Sucampo Pharma Americas, LLC1 个研究点 分布在 1 个国家目标入组 33 人开始时间: 2011年5月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
已完成
入组人数
33
试验地点
1
主要终点
Change in choroidal blood flow

研究概览

简要总结

The purpose of this study is to determine the pharmacodynamics of ocular blood flow measurements with multiple drop unoprostone isopropyl administration versus placebo in subjects with dry age-related macular degeneration (AMD).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
50 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Age ≥ 50 years at screening
  • Ametropy ≤ 3 diopters
  • Clear ocular media
  • Visual acuity in the study eye > 20/40

排除标准

  • Presence of any ocular condition in the study eye (other than AMD) that may progress during the course of the study and could affect central vision, or other ocular conditions that may be a confounding factor in this study
  • Blood donation during the previous 3 weeks
  • Current smoker or a history of smoking within 5 years of enrollment
  • Treatment with protocol-specified prohibited concomitant medications
  • Prior exposure to Rescula (unoprostone isopropyl) and or a known sensitivity to any of the components of the study medication (e.g. benzalkonium chloride)

研究组 & 干预措施

unoprostone isopropyl (3 drop)

Experimental

干预措施: unoprostone isopropyl (Drug)

unoprostone isopropyl (2 drop)

Experimental

干预措施: unoprostone isopropyl (Drug)

结局指标

主要结局

Change in choroidal blood flow

时间窗: In total 6 hours

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验